Singapore Clinical Trial: Exploratory study of Ianalumab in Adults with Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who Have Previously Benefited from Ianalumab (VAY RE-HIT).

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'Exploratory study of Ianalumab in Adults with Primary Immune Thrombocytopenia (ITP) and Warm-antib... और पढ़ें

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascend... और पढ़ें

Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant ... और पढ़ें

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway... और पढ़ें

Singapore Clinical Trial: MK-5684-015: A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selected Solid Tumors (OMAHA-015)

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'MK-5684-015: A Multicenter, Open-label, Phase 2 Basket Study of MK-5684 in Participants With Selec... और पढ़ें

Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safet... और पढ़ें

Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lu... और पढ़ें

Singapore Clinical Trial: A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu] Lu-DFC413 and safety and imaging properties of [68Ga] Ga-NNS309 in patients with solid tumors

Singapore, June 19 -- The Health Sciences Authority received information related to the study titled 'A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and prel... और पढ़ें

Hyundai sub-4m electric SUV spied in South Korea, India launch on the cards?

India, June 19 -- South Korean automaker Hyundai is doubling down on expanding its electric vehicle portfolio. The company is expected to launch a sub-4m electric SUV in the Indian market. The test mu... और पढ़ें

Hot Commodities: Silver crashes below $64 as Fed rate hike worries spark fresh selloff

Mumbai, June 19 -- Silver extended its sharp decline on Friday, plunging below $64 an ounce and touching its lowest level since March, with weekly losses approaching 6%. The metal remains under heavy ... और पढ़ें

• ««
• «
• 19944
• 19945
• 19946
• 19947
• 19948
• 19949
• 19950
• 19951
• 19952
• 19953
• »
• »»